UNSPSC 51182415: Zoledronic acid

This classification denotes a bone density conservation agent with the molecular formula C5H10N2O7P2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6XC1PAD3KF, chemically known as phosphonic acid, (1-hydroxy-2-(1h-imidazol-1-yl)ethylidene)bis- but generally known as zoledronic acid, which bears US NIH Compound Identifier 68740. European Medicines Agency schedules Zoledronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00176MIG.

UNSPSC 51182415 Zoledronic acid (Commodity) shows no relevant recent state and local procurement activity. The three most recent opportunities posted under this code — a District Attorney's Office Dog procurement by Washington County, Oregon; athletic training services for fire and police departments by the City of Tucson; and medical aid supplies by Tampa Fire Rescue — are plainly unrelated to zoledronic acid, a bisphosphonate pharmaceutical used to treat osteoporosis and hypercalcemia. The code assignment appears to be a data-entry error or system mismatch rather than a reflection of genuine purchasing activity.

Without recent solicitations properly tagged to zoledronic acid, no meaningful characterization of issuing-body mix, geographic spread, or market concentration is possible under this code. Firms pursuing pharmaceutical procurement at the state and local level should verify code assignments through the issuing jurisdiction's solicitation portal before investing in proposal development, as this code does not currently surface legitimate pharmaceutical opportunities.